Managing Controversy Through Consultation: a Qualitative Study of Communication and Trust Around MMR Vaccination Decisions
Overview
Authors
Affiliations
Background: Controversy over the measles, mumps, and rubella (MMR) vaccine has reduced uptake, raising concerns of a future disease epidemic.
Aims: To explore parents' accounts of decision making relating to the MMR vaccine controversy, identifying uptake determinants and education needs.
Design Of Study: Qualitative interviews analysed using the 'framework' approach.
Setting: Five general practices in the Leeds area, 2002-2003.
Method: Sixty-nine interviews conducted with parents of children aged between 4 and 5 years, and 12 interviews with primary care practitioners, managers and immunisation coordinators serving participating sites. Participants were interviewed one-to-one in a place of their choice.
Results: The vaccination decision is primarily a function of parental assessments of the relative acceptability and likelihood of possible outcomes. For most parents the evidence of science and medicine plays little role in the decision. Although local general practitioners and health visitors are trusted information sources, the influence of primary care providers on the vaccination decision is limited by concerns over consultation legitimacy, discussion opportunity, and perceptions of financial and political partiality. Parents and practitioners identify a need for new approaches to support decisions and learning when faced with this and similar healthcare controversies. These include new collaborative approaches to information exchange designed to transform rather than supplant existing parent knowledge as part of an ongoing learning process.
Conclusion: The study identified new ways in which parents and practitioners need to be supported in order to increase understanding of medical science and secure more informed decisions in the face of health controversy.
Chisnall G, Hersh-Toubia S, Mounier-Jack S, Letley L, Chantler T BMC Public Health. 2024; 24(1):3434.
PMID: 39696198 PMC: 11653997. DOI: 10.1186/s12889-024-20981-0.
Marhankova J, Kotherova Z, Numerato D Hum Vaccin Immunother. 2024; 20(1):2361943.
PMID: 38855961 PMC: 11168214. DOI: 10.1080/21645515.2024.2361943.
Changes in COVID-19 vaccine hesitancy at different times among residents in Guangzhou, China.
Chen L, Li Z, Lu X, Deng Y, Lu K, Li T Front Public Health. 2023; 11:1164475.
PMID: 37383261 PMC: 10294687. DOI: 10.3389/fpubh.2023.1164475.
Cooper S, Schmidt B, Sambala E, Swartz A, Colvin C, Leon N Cochrane Database Syst Rev. 2021; 10:CD013265.
PMID: 34706066 PMC: 8550333. DOI: 10.1002/14651858.CD013265.pub2.
Lehner L, Gribi J, Hoffmann K, Paul K, Kutalek R BMC Public Health. 2021; 21(1):1671.
PMID: 34521378 PMC: 8442326. DOI: 10.1186/s12889-021-11710-y.